0001104659-17-028860.txt : 20170502
0001104659-17-028860.hdr.sgml : 20170502
20170502155439
ACCESSION NUMBER: 0001104659-17-028860
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170502
DATE AS OF CHANGE: 20170502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEPTULA-HICKS DARLENE M
CENTRAL INDEX KEY: 0001089409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 17804863
MAIL ADDRESS:
STREET 1: C/O ICAD, INC.
STREET 2: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
4
1
a4.xml
4
X0306
4
2017-05-01
0
0001492674
T2 Biosystems, Inc.
TTOO
0001089409
DEPTULA-HICKS DARLENE M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
4.74
2016-05-01
4
A
0
175000
0
A
2027-05-01
Common Stock
175000
175000
D
25% of the total shares vest on 05/01/2018, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 05/01/2021.
/s/ Michael Gibbs, Attorney-in-fact
2017-05-01